Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)

10.1371/journal.pone.0175659

Saved in:

Bibliographic Details
Format:	Erratum
Published:	Public Library of Science 2020
Subjects:	Erratum error
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/166170
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-166170
record_format	dspace
spelling	sg-nus-scholar.10635-1661702022-04-19T03:33:17Z Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209) Erratum error 10.1371/journal.pone.0175659 PLoS ONE 12 4 e0175659 2020-03-31T01:16:39Z 2020-03-31T01:16:39Z 2017 Erratum (2017). Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209). PLoS ONE 12 (4) : e0175659. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0175659 19326203 https://scholarbank.nus.edu.sg/handle/10635/166170 Public Library of Science Unpaywall 20200320
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Erratum error
spellingShingle	Erratum error Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)
description	10.1371/journal.pone.0175659
format	Erratum
title	Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)
title_short	Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)
title_full	Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)
title_fullStr	Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)
title_full_unstemmed	Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)
title_sort	correction: novel synthetic oxazines target nf-κb in colon cancer in vitro and inflammatory bowel disease in vivo (plos one (2016) 11:9 (e0163209) doi: 10.1371/journal.pone.0163209)
publisher	Public Library of Science
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/166170
_version_	1731234871343316992

Correction: Novel synthetic oxazines target NF-κB in colon cancer in vitro and inflammatory bowel disease in vivo (PLoS ONE (2016) 11:9 (e0163209) DOI: 10.1371/journal.pone.0163209)

Similar Items